Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 196 AL 210

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development

Ising C, Stanley M, Holtzman DM.

Clin Pharmacol Ther. 2015 Nov;98(5):469-71. doi: 10.1002/cpt.200. Epub 2015 Sep 10.

Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances

Yin Y, Liu Y, Zhuang J, Pan X, Li P, Yang Y, Li YP, Zhao ZQ, Huang LQ, Zhao ZX.

Pharmacology. 2015;96(3-4):155-62. doi: 10.1159/000435889. Epub 2015 Aug 8.

Leptin in Alzheimer's disease

Magalhães CA, Carvalho MG, Sousa LP, Caramelli P, Gomes KB.

Clin Chim Acta. 2015 Oct 23;450:162-8. doi: 10.1016/j.cca.2015.08.009. Epub 2015 Aug 14.

Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed

Lacey L, Bobula J, Rüdell K, Alvir J, Leibman C.

Value Health. 2015 Jul;18(5):638-45. doi: 10.1016/j.jval.2015.03.1787. Epub 2015 Apr 10.

To Feed or Not to Feed? A Case Report and Ethical Analysis of Withholding Food and Drink in a Patient With Advanced Dementia

Meier CA, Ong TD.

J Pain Symptom Manage. 2015 Dec;50(6):887-90. doi: 10.1016/j.jpainsymman.2015.07.009. Epub 2015 Aug 20.

Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease

Kuzmickienė J, Kaubrys G.

Med Sci Monit. 2015 Aug 31;21:2572-82. doi: 10.12659/MSM.895381.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.

Circadian rhythm in Alzheimer disease after trazodone use

Grippe TC, Gonçalves BS, Louzada LL, Quintas JL, Naves JO, Camargos EF, Nóbrega OT.

Chronobiol Int. 2015;32(9):1311-4. doi: 10.3109/07420528.2015.1077855. Epub 2015 Sep 16.

Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?

Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, Kalaria RN, Anand A.

J Alzheimers Dis. 2015;47(4):815-43. doi: 10.3233/JAD-150136.

Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease

Gleason CE, Fischer BL, Dowling NM, Setchell KD, Atwood CS, Carlsson CM, Asthana S.

J Alzheimers Dis. 2015;47(4):1009-19. doi: 10.3233/JAD-142958.

Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F.

J Alzheimers Dis. 2015;48(2):377-83. doi: 10.3233/JAD-141983.

Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study

Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.

J Alzheimers Dis. 2015;48(2):473-81. doi: 10.3233/JAD-150414.

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J.

J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.

Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)

Matsuzono K, Sato K, Kono S, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K.

J Alzheimers Dis. 2015;48(3):757-63. doi: 10.3233/JAD-150518.

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Bukhari SN, Jantan I.

Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias